'Norvir' diaporamas de présentation

Alternative Access Strategies

Alternative Access Strategies. Peter Maybarduk / UAEM Decal 98/198 Spring 2007. Questions:. How can society most efficiently purchase research and development, and hence create lifesaving medicines? What is the proper balance of private incentive and public benefit?. Social Purpose of IP.

855 views • 65 slides

HIV Drugs, Updates, & the Hope for Entry Inhibitors Kent Williams

HIV Drugs, Updates, & the Hope for Entry Inhibitors Kent Williams Doctor of Pharmacy Candidate 2011 Wingate University School of Pharmacy Saturday, February 19, 2011. Disclosures. I have no conflicts of interest in regard to this program.

618 views • 52 slides

HIV Care 2010: The 3 rd Revolution in HIV treatment

HIV Care 2010: The 3 rd Revolution in HIV treatment. Chris Farnitano, MD Noon Conference February 11, 2010. Learning Objectives. Be familiar with recent advances in anti-HIV medications Know the new threshold for initiating HIV treatment according to the December, 2009 DHHS guidelines

604 views • 47 slides

Wignot Research Projects

415 views • 29 slides

Understanding Pharmacokinetics & Drug-Drug Interactions

848 views • 29 slides

ARV failure and resistance for the paediatrician

ARV failure and resistance for the paediatrician. Douglas Watson, M.D. University of Maryland 11 December 2013. REVERSE TRANSCRIPTASE INHIBITORS (NRTIs & NNRTIs). Integrase inhibitors. Fusion Inhibitors. PROTEASE INHIBITORS. Attachment Inhibitors. HIV DRUG TARGETS.

497 views • 28 slides

Retroviruses ???? (C65, p657) l Viruses are named because of reverse transcriptase .

Retroviruses ???? (C65, p657) l Viruses are named because of reverse transcriptase . l Family members are listed in Table 1 and Fig. 1. l Human pathogens include HTLV-1, -2 and HIV-1, -2. 1. Structure: +ssRNA (about 9 kb for HIV) X2, capsid and envelope) (Fig. 3).

369 views • 23 slides